Legislation – The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020

New Search

Introduction

1 Citation and commencement

2 Amendment of the Human Medicines Regulations 2012

3 Amendment of regulation 8

4 Amendment of regulation 19

5 Amendment of regulation 41

6 New regulation 174A

7 Amendment of regulation 229

8 Amendment of regulation 230

9 Amendment of regulation 231

10 Amendment of regulation 233

11 Amendment of regulation 234

12 Amendment of regulation 235

13 Amendment of regulation 247

14 New regulation 247A

15 Amendment of regulation 250

16 Amendment of regulation 277

17 Amendment of regulation 279

18 Amendment of regulation 280

19 Amendment of regulation 281

20 Amendment of regulation 284

21 Amendment of regulation 285

22 Amendment of regulation 287

23 Amendment of regulation 291

24 New regulation 291A

25 Amendment of regulation 293

26 Amendment of regulation 294

27 Amendment of regulation 295

28 Amendment of regulation 297

29 Amendment of regulation 345

30 Amendment of regulation 346

31 Amendment of Schedule 1

32 Amendment of Schedule 17

33 Amendment of Schedule 30

Signature

Explanatory note

Amendment of regulation 28018.

In regulation 28018 (general principles), after paragraph (3) insert—

“(4)

A person may not publish an advertisement for a medicinal product in relation to which there is in force an authorisation by the licensing authority on a temporary basis under regulation 174 (but not an authorisation, certificate or registration as mentioned in regulation 279(a) or (b) to (d)), unless it is published as part of a campaign that has been approved by the Ministers.”.